Hero Technologies Inc. (HENC) Financial Statements (2025 and earlier)
Company Profile
Business Address |
8 THE GREEN DOVER, DE 19901 |
State of Incorp. | NV |
Fiscal Year End | December 31 |
Industry (SIC) | 2833 - Medicinal Chemicals and Botanical Products (benchmarking) |
More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) (USD)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | |||
---|---|---|---|---|---|---|---|---|---|
ASSETS | |||||||||
Current Assets | |||||||||
Cash, cash equivalents, and short-term investments | 98,199 | 19,190 | 34,325 | 128,629 | 189,684 | 121,537 | |||
Cash and cash equivalents | 98,199 | 19,190 | 34,325 | 128,629 | 189,684 | 121,537 | |||
Receivables | 15,000 | ||||||||
Prepaid expense | 12,500 | 3,282 | 6,563 | 9,844 | 13,124 | 4,122 | |||
Other undisclosed current assets | 50,000 | (15,000) | 620 | 620 | 620 | ||||
Total current assets: | 160,699 | 22,472 | 40,888 | 139,093 | 203,428 | 126,279 | |||
Noncurrent Assets | |||||||||
Property, plant and equipment | 3,440 | 603,833 | 604,329 | 4,827 | 5,323 | 5,817 | |||
Total noncurrent assets: | 3,440 | 603,833 | 604,329 | 4,827 | 5,323 | 5,817 | |||
TOTAL ASSETS: | 164,139 | 626,305 | 645,217 | 143,920 | 208,751 | 132,096 | |||
LIABILITIES AND EQUITY | |||||||||
Liabilities | |||||||||
Current Liabilities | |||||||||
Debt | 525,000 | 525,000 | |||||||
Due to related parties | ✕ | ✕ | 200,000 | 200,000 | 200,000 | 200,000 | 200,000 | ||
Other undisclosed current liabilities | 99,774 | 117,905 | 110,540 | 62,266 | 53,698 | 39,847 | |||
Total current liabilities: | 99,774 | 842,905 | 835,540 | 262,266 | 253,698 | 239,847 | |||
Noncurrent Liabilities | |||||||||
Total liabilities: | 99,774 | 842,905 | 835,540 | 262,266 | 253,698 | 239,847 | |||
Equity | |||||||||
Equity, attributable to parent, including: | 64,365 | (216,600) | (190,323) | (118,346) | (44,947) | (107,751) | |||
Preferred stock | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | 1,000 | |||
Common stock | 465,192 | 461,192 | 451,692 | 450,623 | 447,907 | 445,907 | |||
Additional paid in capital | 39,106,374 | 39,012,032 | 38,846,282 | 38,801,893 | 38,710,779 | 38,612,779 | |||
Accumulated deficit | (40,584,171) | (39,583,013) | (39,397,693) | (39,291,611) | (39,133,607) | (39,101,706) | |||
Other undisclosed equity, attributable to parent | 1,075,970 | (107,811) | (91,604) | (80,251) | (71,026) | (65,731) | |||
Total equity: | 64,365 | (216,600) | (190,323) | (118,346) | (44,947) | (107,751) | |||
TOTAL LIABILITIES AND EQUITY: | 164,139 | 626,305 | 645,217 | 143,920 | 208,751 | 132,096 |
Income Statement (P&L) (USD)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Operating expenses | 924,045 | 172,793 | 919,645 | (167,229) | (37,298) | 208,138 | ||
Operating income (loss): | 924,045 | 172,793 | 919,645 | (167,229) | (37,298) | 208,138 | ||
Nonoperating income (expense) | (77,113) | (13,734) | (23,120) | 102 | (37,831) | |||
Investment income, nonoperating | 15,000 | |||||||
Interest and debt expense | (4,394) | (13,917) | 37,292 | (81) | (37,831) | |||
Other undisclosed loss from continuing operations before equity method investments, income taxes | (1,013,340) | |||||||
Income (loss) from continuing operations: | 842,538 | 145,142 | (79,523) | (167,229) | (37,277) | 132,476 | ||
Income (loss) before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (167,229) | (37,277) | 132,476 | |
Other undisclosed net income (loss) | (1,843,696) | (331,669) | (37,912) | 81 | (378,072) | |||
Net loss: | (1,001,158) | (186,527) | (117,435) | (167,229) | (37,196) | (245,596) | ||
Net income (loss) attributable to noncontrolling interest | (11,353) | (9,225) | 5,295 | (373) | ||||
Other undisclosed net income attributable to parent | 1,207 | 22,706 | 18,450 | 373 | ||||
Net loss available to common stockholders, diluted: | (1,001,158) | (185,320) | (106,082) | (158,004) | (31,901) | (245,596) |
Comprehensive Income (USD)Annual | Quarterly
9/30/2023 Q3 | 6/30/2023 Q2 | 3/31/2023 Q1 | 12/31/2022 Q4 | 9/30/2022 Q3 | 6/30/2022 Q2 | 3/31/2022 Q1 | ||
---|---|---|---|---|---|---|---|---|
Net loss: | (1,001,158) | (186,527) | (117,435) | (167,229) | (37,196) | (245,596) | ||
Comprehensive loss: | (1,001,158) | (186,527) | (117,435) | (167,229) | (37,196) | (245,596) | ||
Comprehensive income (loss), net of tax, attributable to noncontrolling interest | (11,353) | (9,225) | 5,295 | (373) | ||||
Comprehensive loss, net of tax, attributable to parent: | (1,001,158) | (186,527) | (128,788) | (176,454) | (31,901) | (245,969) |
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.